Camber Capital Management as of Sept. 30, 2020
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 35 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Change Healthcare | 11.5 | $218M | 15M | 14.51 | |
| Mylan N V Shs Euro | 9.4 | $178M | 12M | 14.83 | |
| Alexion Pharmaceuticals | 7.8 | $149M | 1.3M | 114.43 | |
| Perrigo SHS (PRGO) | 6.9 | $131M | 2.9M | 45.91 | |
| Universal Hlth Svcs CL B (UHS) | 6.5 | $123M | 1.2M | 107.02 | |
| Alkermes SHS (ALKS) | 6.3 | $120M | 7.3M | 16.57 | |
| Hca Holdings (HCA) | 4.8 | $90M | 725k | 124.68 | |
| Bausch Health Companies (BHC) | 3.7 | $70M | 4.5M | 15.54 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 3.4 | $65M | 7.3M | 8.99 | |
| Myriad Genetics (MYGN) | 3.4 | $65M | 5.0M | 13.04 | |
| Sarepta Therapeutics (SRPT) | 3.1 | $60M | 425k | 140.43 | |
| Bluebird Bio (BLUE) | 3.1 | $59M | 1.1M | 53.95 | |
| Pacific Biosciences Calif In | 2.3 | $44M | 4.4M | 9.87 | |
| Cigna Corp (CI) | 2.2 | $42M | 250k | 169.41 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.2 | $42M | 2.0M | 20.82 | |
| Nektar Therapeutics (NKTR) | 2.2 | $42M | 2.5M | 16.59 | |
| AMAG Pharmaceuticals | 2.2 | $41M | 4.4M | 9.40 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.1 | $41M | 4.5M | 9.01 | |
| Coherus Biosciences (CHRS) | 2.1 | $40M | 2.2M | 18.34 | |
| Brookdale Senior Living (BKD) | 2.0 | $38M | 15M | 2.54 | |
| OraSure Technologies (OSUR) | 1.8 | $34M | 2.8M | 12.17 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $30M | 400k | 76.08 | |
| Puma Biotechnology (PBYI) | 1.4 | $26M | 2.6M | 10.09 | |
| Tenet Healthcare Corp Com New (THC) | 1.3 | $25M | 1.0M | 24.51 | |
| Radius Health Com New | 1.2 | $24M | 2.1M | 11.34 | |
| Avrobio Ord (AVRO) | 1.2 | $23M | 1.8M | 13.02 | |
| Atara Biotherapeutics | 1.0 | $18M | 1.4M | 12.96 | |
| Glaxosmithkline Sponsored Adr | 0.9 | $17M | 450k | 37.64 | |
| Immunovant (IMVT) | 0.8 | $15M | 439k | 35.19 | |
| Dicerna Pharmaceuticals | 0.5 | $9.4M | 525k | 17.99 | |
| Glycomimetics (GLYC) | 0.4 | $7.7M | 2.5M | 3.07 | |
| Sutro Biopharma (STRO) | 0.3 | $6.0M | 600k | 10.05 | |
| Global Blood Therapeutics In | 0.1 | $2.8M | 50k | 55.14 | |
| Vir Biotechnology (VIR) | 0.0 | $565k | 17k | 34.32 | |
| AngioDynamics (ANGO) | 0.0 | $252k | 21k | 12.07 |
